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Summary The stress hormone cortisol is important for the regulation of social motivational
processes. High cortisol levels have been associated with social fear and avoidance, which play an
important role in social anxiety disorder (SAD), as does hypervigilant processing of social threat.
However, causal effects of cortisol on threat processing in SAD remain unclear. In an event-related
potential (ERP) study we investigated the effects of cortisol on task-irrelevant (implicit)
processing of social threat in SAD, exploring the temporal dynamics as well as the role of
symptom severity and stimulus awareness. Angry face processing was measured in participants
with clinical SAD after double-blind, within-subject oral administration of cortisol (50 mg) and
placebo, using a masked and an unmasked emotional Stroop task. Both tasks showed significantly
increased P2 midline ERP amplitudes for angry compared to neutral and happy faces in the
placebo condition, reflecting an early attentional bias for social threat in SAD. Furthermore,
cortisol administration significantly decreased P2 amplitudes for masked angry faces. This effect
correlated with social anxiety, showing stronger decreases in patients with higher levels of social
anxiety. These results indicate a highly specific effect of cortisol on early motivated attention to
social threat and, together with previous findings, highlight the importance of motivational
context (stimulus- or task-relevance) as well as symptom severity.
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Social anxiety disorder (SAD, or social phobia) is character-
ized by intense fear and avoidance of social situations.
Cognitive models of SAD suggest that it is associated with
biases in attending to threat-related information, and thatd.
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development and maintenance of anxiety symptoms (see
e.g., Clark and Wells, 1995; Rapee and Heimberg, 1997;
Mobini and Grant, 2007; Schultz and Heimberg, 2008). There
is, however, no consensus about the specific processing stages
in which these biases occur. In the present study we aim to
gain more insight in the temporal dynamics of biased proces-
sing of social threat in SAD, by investigating event-related
potentials (ERPs) during masked and unmasked versions of a
pictorial emotional Stroop task. In addition, recent neuro-
biological accounts propose that increased social fear and
avoidance as found in SADmay be related to high levels of the
stress hormone cortisol (e.g., Condren et al., 2002; Hermans
and van Honk, 2006; Roelofs et al., 2009). However, causal
effects of cortisol on threat processing remain unclear.
Therefore, our second purpose was to investigate the effect
of cortisol administration on social threat processing in SAD.
Although a wide range of studies has provided empirical
evidence for biased processing of social threat in SAD (see
e.g., Bar-Haim et al., 2007; Mobini and Grant, 2007 for
reviews), results are conflicting with regard to the direction
of this bias. Several studies have found a bias towards threat
(or threat vigilance) in socially anxious participants, as indi-
cated by longer reaction times (RT) for color-naming threat
vs. neutral stimuli in emotional Stroop tasks (e.g., Mattia
et al., 1993; Amir et al., 2002; Spector et al., 2003) or
speeded responses to threat cues in spatial attention para-
digms such as dot-probe or visual search tasks (e.g., Asmund-
son and Stein, 1994; Gilboa-Schechtman et al., 1999; Mogg
and Bradley, 2002; Musa et al., 2003; Mogg et al., 2004).
Other studies, however, reported a bias away from threat (or
threat avoidance) in socially anxious participants, as indi-
cated by shorter RTs for threat vs. neutral stimuli in emo-
tional Stroop tasks (Putman et al., 2004) or longer RTs to
threat cues in dot-probe tasks (e.g., Mansell et al., 1999;
Chen et al., 2002). Although these discrepant findings may be
in part related to variation in experimental paradigms (e.g.,
Stroop vs. dot-probe) or stimulus materials (words vs. face
pictures) (see Bar-Haim et al., 2007; Mobini and Grant, 2007),
an alternative explanation is that the direction of the atten-
tional bias is related to the timing of the effects that are
tapped by a specific paradigm, and depends on different
underlying cognitive processes. According to the hypervigi-
lance-avoidance hypothesis (Mogg et al., 1997; Mogg and
Bradley, 2002), anxious participants may initially orient
towards threat, but subsequently direct their attention away
in order to reduce their anxiety levels. Although some recent
studies provided support for this hypothesis in individuals
with SAD (Amir et al., 1998; Mogg et al., 2004), RT data as
used in these studies reflect the product of a range of
cognitive processes and may therefore be less sensitive for
differentiating between biases in early or late stages of
information processing. In contrast, event-related potentials
(ERPs) recorded from the scalp provide a continuous and high
temporal resolution measure of the extent (amplitude) and
speed (latency) of cerebral processing, and are therefore
particularly suitable for a more refined investigation of the
time course of attention allocation to stimuli during emo-
tional processing.
ERPs have been widely used to study processing of emo-
tional material, often including pictures of angry or fearful
faces as social threat stimuli. Results of these studies inhealthy participants have shown very rapid effects (i.e.,
< 250 ms post-stimulus) suggesting early preferential proces-
sing of threat-related emotional faces (Eimer and Holmes,
2002; Eger et al., 2003; Ashley et al., 2004; Bar-Haim et al.,
2005; Williams et al., 2006), as well as modulation of later
stages of threat processing (Eimer and Holmes, 2002; Schupp
et al., 2004; Williams et al., 2006). However, studies using
ERPs to investigate threat processing in SAD are relatively
scarce. In three recent studies Kolassa et al. (Kolassa and
Miltner, 2006; Kolassa et al., 2007, 2009) investigated threat
processing in patients with SAD using angry compared to
neutral and happy faces. Two of these studies (Kolassa
et al., 2007, 2009) showed no differential processing of angry
faces in SAD during either color or explicit emotion identi-
fication of schematic faces. Results of the other study
(Kolassa and Miltner, 2006) showed biased early processing
of angry photographic faces in patients with SAD, as reflected
by enhanced right temporo-parietal N170 amplitudes, during
explicit emotion identification but not when emotion proces-
sing was implicit (i.e., during gender identification). As
suggested by Bar-Haim et al. (2007), biased processing during
explicit emotion identification may be contingent on the
stimulus being task-relevant, which hinders the generaliz-
ability of such findings. Furthermore, both of these studies
(Kolassa and Miltner, 2006; Kolassa et al., 2007) focused only
on occipito-temporal and parietal electrodes and did not
report on the early and late midline positive ERP components
that have consistently demonstrated emotional expression
effects in healthy participants (see Holmes et al., 2008), and
were also shown to be enhanced during implicit angry face
processing in high anxious healthy participants (Bar-Haim
et al., 2005). Thus, the first aim of the present study was
to gain more insight in the temporal dynamics of implicit
threat processing in SAD by investigating midline positive
ERPs during color-naming in a modified emotional Stroop task
with photographic faces. We also included a masked version
of this task, to investigate threat processing biases under
conditions of restricted awareness.
Our second aim was to investigate the effects of cortisol
administration on implicit threat processing in SAD. The
stress hormone cortisol plays an important role in the reg-
ulation of social motivational processes (e.g., Kalin et al.,
1998; van Honk et al., 1998, 2000; Sapolsky et al., 2000;
Roelofs et al., 2005, 2009; van Peer et al., 2007), and high
cortisol stress-responses have been associated with increased
threat avoidance in SAD (Roelofs et al., 2009). Furthermore,
cortisol administration has recently been proposed as a
possible treatment for SAD, because it reduced self-reported
anxiety in social phobic patients during exposure to socio-
evaluative threat (e.g., Soravia et al., 2006; De Quervain and
Margraf, 2008). However, relatively little is known about the
effects of cortisol administration on cognitive-emotional
processes such as attention to threat. A few recent studies,
using explicit emotion evaluation paradigms, showed that
cortisol administration can increase angry face processing,
especially in high anxious individuals (Putman et al., 2007a;
van Peer et al., 2007, 2009). In the present study, we
investigate whether cortisol administration has similar
effects on the implicit (task-irrelevant) processing of threat.
Implicit threat processing will be measured by recording
ERPs during color-identification of angry, happy and neutral
faces in both a subliminal (masked) and a supraliminal
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tasks are administered in both a placebo and a cortisol
administration condition, using a within-subject design.
Based on the hypervigilance-avoidance hypothesis (e.g.,
Mogg et al., 1997) and previous findings of enhanced early
threat processing in high anxious participants (e.g., Bar-Haim
et al., 2005; Holmes et al., 2008) we expect to find relatively
increased early positive midline amplitudes for angry faces in
the placebo condition. This effect may be followed by shorter
color-naming latencies for angry faces, reflecting threat
avoidance (see Putman et al., 2004). Furthermore, we will
test whether, and at which stage, this threat processing is
affected by cortisol administration.
2. Methods
2.1. Participants
Eighteen unmedicated patients with SAD participated in the
experiment for financial compensation. Group characteris-
tics are presented in Table 1. Patients were recruited at the
outpatient departments of three community mental health
centers and through advertisements on internet forums.
Inclusion criteria were: a primary diagnosis of generalized
SAD (according to DSM-IV criteria) and a total score > 60 at
the Liebowitz Social Anxiety Scale (Liebowitz, 1987), right-
handedness, normal or corrected-to-normal vision, and age
18—55 years. Exclusion criteria were current diagnosis of
major depressive disorder, pregnancy or breast-feeding,
clinical significant medical disease, past head injury with
loss of consciousness >5 min, use of psychotropic medica-
tion, use of corticosteroids in the 6 months prior to participa-
tion, use of cannabis more than once a week or use of anyTable 1 Patient characteristics (n = 17).
Measure M SD
Age (years) 31.4 10.0
BDI 12.7 6.1
LSAS fear 43.2 7.1
LSAS avoidance 36.5 10.8
LSAS total 79.7 15.9
SPAI social phobia 132.4 20.9
SPAI agoraphobia 26.4 10.0
SPAI total 106.0 21.3
Axis-1 comorbiditya
Comorbid anxiety disorderb n = 0
Current mood disorderc n = 0
Note: (Scale range between parentheses). BDI = Beck Depression
Inventory (0—63); LSAS = Liebowitz Social Anxiety Scale (fear 0—
72, avoidance 0—72, total 0—144); SPAI = Social Phobia and Anxi-
ety Inventory (social phobia 0—192, agoraphobia 0—78,
total = SP Ag).
a Assessed using the Structured Clinical Interview for DSM-IV
Axis-I Disorders (SCID-I).
b Including panic disorder, agoraphobia, specific phobia, obses-
sive compulsive disorder, post-traumatic stress disorder and gen-
eralized anxiety disorder.
c Including current major depressive episode, mania, hypoma-
nia, dysthymic disorder, and bipolar disorder.drugs other than cannabis in the 3 months prior to participa-
tion, and use of more than three glasses of alcohol or 20
cigarettes per day. Participants were instructed to minimize
physical exercise, not to take large meals, chocolate or
caffeine during the morning preceding the experiment,
and not to eat, drink low pH drinks or smoke cigarettes in
the hour before the start of the experiment, because these
variables can affect saliva cortisol measures. All participants
provided written informed consent prior to participation in
the study, which was approved by the Medical Ethical Com-
mittee of the Leiden University Medical Center. Of the 18
patients tested, one had to be excluded because of missing
reaction time data due to technical problems, leaving a total
number of 17 participants (7 male, 10 female).
Participants were screened using the Structured Clinical
Interview for DSM-IVAxis I Disorders (SCID-I: First et al., 1996)
by a trained psychologist at the end of the first testing day to
confirm diagnosis for social anxiety disorder and to exclude
current major depressive disorder. Participants also com-
pleted Dutch versions of the Social Phobia and Anxiety Inven-
tory (SPAI: Turner et al., 1989), and the Beck Depression
Inventory (Beck et al., 1979). See Table 1 for questionnaire
values.
2.2. Materials and procedure
All participants were tested in a cortisol and a placebo
condition in a double-blind, within-subject crossover design.
The order of cortisol (50 mg hydrocortisone) or placebo
(primogel FNA) administration was random and balanced
over all participants. The two experimental sessions were
1 week apart. On the days of testing, participants arrived at
the laboratory at 1215 h. After a short introduction, drugs
were administered orally at 1230 h, followed by a resting
period of 1 h to allow for the cortisol to take effect. During
this period, participants completed questionnaires, after
which the electrodes for the electrophysiological measure-
ments were placed. The experiment started with a short
recording of the resting state electroencephalogram (EEG),
followed by a number of additional cognitive tests of which
the results will be reported elsewhere (see e.g., van Peer
et al., 2009). The emotional Stroop task (15 min) was
administered at the end of the experiment, approximately
2.5 h after capsule intake. During task performance, parti-
cipants sat in an air-conditioned and sound-attenuated room
in front of a computer monitor, and the experimenter sat in
an adjacent room where the EEG apparatus was located.
2.3. Cortisol and subjective measures
Saliva samples were obtained using Salivette collection
devices (Sarstedt, Rommelsdorf, Germany). Samples were
obtained at four assessment points over a 165 min period, at
respectively 5 min (T0), +60 min (T1), +120 min (T2), and
+160 min (T3) with reference to capsule ingestion. Biochem-
ical analysis of free cortisol in saliva was performed using a
competitive electrochemiluminescence immunoassay
(ECLIA, Elecsys 2010, Roche Diagnostics), as described else-
where (van Aken et al., 2003).
Self-reported mood (tension, fatigue, depression, anxi-
ety, and activation) was rated on 100 mm visual analogue
1 In addition to the analyses reported below, repeated measures
ANOVAs including the factor drug order (cortisol first session or
second session) were performed to investigate possible order effects
related to repeated administration of the emotional Stroop task. The
results of these analyses showed no significant differences between
the first and second session in the placebo or the cortisol condition,
for either the color-naming latencies or the ERP amplitudes per
electrode. Therefore, this factor was not further included in the
analyses.
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(STAI-state: Spielberger, 1983) was measured at T0 and T3.
2.4. Emotional Stroop task
Stimuli consisted of photographs of eight actors (four
female), each displaying a happy, a neutral and an angry
expression (Ekman and Friesen, 1976; Lundqvist et al.,
1998). An oval area centered on the face was extracted to
remove the hair and non-facial contours. The pictures were
equalized in luminance, and colored with a red, green or
blue filter. Masking stimuli consisted of oval configurations of
randomly cut and reassembled fragments of face stimuli
(van Honk et al., 1998). The total stimulus set consisted
of 72 target face stimuli (8 actors  3 expressions  3 colors)
and 6 masks (2 different  3 colors). Stimulus presentation
and response loggingwere controlled using E-prime software
and a serial voice response box and microphone (Psychology
Software Tools, inc.). The emotional Stroop task was admi-
nistered in four phases. Participants started with a practice
block of nine trials in which only masks were presented.
Next, they completed a masked version of the task of 72
randomized trials. Each trial started with a 750 ms fixation
cross, followed by a very brief (16.7 ms, 2 frames at 120 Hz)
exposure to a target face, which was replaced by a mask of
the same color. Participants were instructed to name this
color as fast as possible, and vocal response initiation trig-
gered offset of the masks. New trials started after a random
inter-trial interval of 2—4 s. The masked version was fol-
lowed by an unmasked version of the task, which differed
only in absence of the masks. Thus, the target stimuli
remained visible until registration of responses. To deter-
mine whether participants were capable of consciously
perceiving the masked facial expressions, the final phase
of the task consisted of an awareness check in which a subset
of 48 masked faces (each actor and expression twice) was
presented to the participants. The instructions explicitly
stated that the stimuli consisted of briefly presented faces
and participants were asked to indicate (if necessary by
guessing) whether the emotional expression of these faces
was happy, neutral, or angry by pressing the corresponding
response button.
Responses during the masked and unmasked version of
the emotional Stroop task were audio-recorded, and incor-
rect responses (1.3%) were excluded from the analyses.
Reaction times outliers were filtered by using a <200 and
>1300 ms cut-off, and subsequent removal of all RTs
exceeding 2.5SD from the individual participants’ mean
(per task and session). These trials were also excluded from
the ERP analyses. Remaining latencies (89.7% of all trials)
were averaged over the facial expression types for each
task and condition. Statistical analyses were performed
using separate repeated measures ANOVAs for the masked
and the unmasked task version, with condition (placebo,
cortisol) and stimulus emotion (angry, neutral, happy) as
within-subject factors.
2.5. Electrophysiological recording and analyses
The electroencephalogram (EEG) was recorded from 19 scalp
locations according to the international 10—20 system andreferred on-line to C3/C4. An average earlobe reference was
derived off-line. Vertical electro-oculogram (EOG) was
recorded bipolarly from the supraorbital and the infraorbital
ridge of the right eye, and horizontal EOG from the outer
canthi of both eyes. The ground electrodewas located at Fpz.
EEG impedances were kept below 5 kV. The EEG and EOG
signals were digitized at 500 Hz and segmented off-line (using
Brain Vision Analyzer software, version 1.05, Brain Products
GmbH, 1998—2004) into 1000 ms epochs, from 200 ms before
to 800 ms after stimulus onset. Trials with incorrect
responses and outlier reaction times were excluded from
the analyses. Single trials were corrected for the effects of
eye blinks and eye movements using a standard procedure
(Gratton et al., 1983). Data were filtered digitally with a
0.1 Hz high-pass filter (24 dB/oct roll-off) and a 35 Hz low-
pass filter (24 dB/oct). Artifact rejection was performed by
removing epochs with activity below 0.50 mV for >100 ms,
amplitudes exceeding 75 mV, a voltage step per sampling
point>50 mV, and an absolute difference between two values
>100 mV. Because of many artifacts in either the F3/F4 or the
occipito-temporal (OT) electrodes, artifact rejection and
further processing was performed separately for the midline
(Fz, Cz, Pz) and the OTelectrodes (O1, O2, T5, T6) in order to
include as many trials as possible in each analysis.
Separate averages were computed for happy, angry and
neutral faces as a function of task (masked, unmasked). Six
components (P2, N2 and P3 at midline electrodes, and N170,
P1, and P2 at OT electrodes) were quantified from the
individual participants’ waveforms. Peak amplitudes of
these components were identified automatically as local
maximum relative to the 200 ms pre-stimulus baseline in
defined latency ranges, with manual confirmation. At mid-
line electrodes the P2 (100—250 ms) and N2 (175—300 ms)
amplitudes were time-locked to Cz, and P3 amplitude (275—
500 ms) was time-locked to Pz (Picton et al., 2000). At OT
electrodes N170 amplitude (110—190 ms) was identified at
T5 and T6, and P1 (60—140 ms) and P2 (180—260 ms) ampli-
tudes at O1 and O2.
The influence of cortisol administration on subjective
measures, salivary cortisol, emotional Stroop task perfor-
mance, and ERP peak amplitudes were tested with repeated
measures analyses of variance (ANOVAs) using the Statistical
Package for the Social Sciences (SPSS 14.0, SPSS Inc., 1989—
2005).1 For the ERP measures, only results involving signifi-
cant main or interaction effects including Emotion or Con-
dition will be reported. All statistical analyses employed a
two-tailed alpha of 0.05. Effect sizes of significant results are
reported as proportion of explained variance (partial eta
squared [h2]). The Greenhouse-Geisser correction was used
when appropriate (epsilon [e]).
Table 2 Mean free salivary cortisol levels (nmol/l) after
placebo and cortisol administration relative to time of cap-
sule intake (t = 0).
Time (min) Placebo Cortisol
M SD M SD
5 9.9 3.5 9.9 3.7
+60 *** 8.3 2.8 270.6 211.0
+120 *** 7.4 2.6 206.5 189.6
+165 *** 6.6 2.4 142.7 157.6
*** p < 0.001 placebo vs. cortisol.
Table 3 Means (and SD) of color-naming latencies (ms).
Masked Unmasked
Placebo
Angry faces 661 (123) 702 (134)
Neutral faces 657 (106) 698 (105)
Happy faces 670 (119) 704 (143)
Cortisol
Angry faces 649 (131) 669 (140)
Neutral faces 639 (128) 674 (144)
Happy faces 641 (119) 667 (138)
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3.1. Cortisol and subjective measures
Salivary cortisol (nmol/l) measures (see Table 2) were
skewed and therefore log transformed before statistical
analysis. The data of one participant were excluded from
the cortisol analyses due to unreliable saliva measurements.
The results of a 2  4 repeated measures ANOVA with Con-
dition (placebo, cortisol) and Time (T0, T1, T2, T3) yielded a
significant main effect of Condition, F(1,15) = 168.41,
p = 0.000, h2 = 0.92, and Time, F(3,45) = 45.08, p = 0.000,
h2 = 0.45, as well as a significant interaction of Condi-
tion  Time, F(3,45) = 63.72, p = 0.000, h2 = 0.81. Follow-
up F-tests showed that, as expected, salivary cortisol levels
did not differ between conditions before capsule intake (T0),
F(1,15) = 0.022, p = 0.88), but were significantly increased
after cortisol administration compared to placebo from 1 h
after capsule intake until the end of the experiment (T1:
F(1,15) = 117.53, p = 0.000, h2 = 0.89; T2: F(1,15) = 149.87,
p = 0.000, h2 = 0.91; T3: F(1,15) = 106.46, p = 0.000,
h2 = 0.88). Note that the emotional Stroop task was adminis-
tered between T2 and T3 (i.e., between 2 and 2.5 h after
capsule intake).
To investigate effects of cortisol administration on sub-
jective mood (data not shown) we conducted separate
repeated measures ANOVAs with Condition (placebo, corti-
sol)  Time for STAI-state (T0, T3), and VAS tension, fatigue,
depression, anxiety, and activation (T0, T1, T3). Results
showed no significant main or interaction effects of Condition
on any of the subjective mood measures, except for a trend
of Condition on VAS activation (F(1,16 = 4.42, p = 0.052,
h2 = 0.21; all other Fs < 1.73, ps > 0.21, h2s < 0.10). Fol-
low-up analyses revealed that reported activation was higher
in the placebo compared to the cortisol condition before
capsule intake (T0: F(1,16) = 5.33, p = 0.035, h2 = 0.25; pla-
cebo: M = 52.8, SD = 17.4; cortisol: M = 40.7, SD = 14.2), but
not after capsule intake (T1: F(1,16) = 2.56, p = 0.13,
h2 = 0.14; T3: F(1,16) = 0.39, p = 0.54, h2 = 0.02), indicating
that this effect was not due to cortisol administration.
3.2. Behavioral results
3.2.1. Awareness check
A paired samples t-test showed that the number of correct
responsesontheawareness checkdidnotdiffer asa functionof
condition (placebo vs. cortisol). We therefore pooled the dataof the two separate measures together to provide a more
reliable measure of awareness during emotional Stroop per-
formance (see Putman et al., 2007b). For a binomial test with
n = 96andP = 0.33, the individual cut-off score (p < 0.05) lies
at 41 correct responses. Of the 17 participants, five partici-
pants scored 44 or more on the test, and results of the masked
task will therefore be reported with and without these parti-
cipants. Themean number of correct responses of the remain-
ing 12 participants was 33.9 (SD = 2.9).
3.2.2. Reaction times
Repeated measures ANOVAs with Condition (placebo, corti-
sol) and Emotion (angry, happy, neutral) showed no signifi-
cant effects on color-naming latencies in either the masked
task version, all Fs < 1.25, ps > 0.28 (without the five parti-
cipants that scored above chance level at the awareness
check, all Fs < 1.9, ps > 0.19), or the unmasked task version,
all Fs < 3.16, ps > 0.090. See Table 3.
3.3. ERP results masked task: midline electrodes
(Fz, Cz, Pz)
See Figure 1 for grand average ERPs at Fz, Cz, and Pz in the
masked task.
3.3.1. P2 amplitude
The repeated measures ANOVA with Condition (placebo, cor-
tisol), Emotion (angry, happy, neutral) and Electrode (Fz, Cz,
Pz) showed a significant interaction of Condition  Emotion on
the P2 amplitudes in the masked task version, F(2,32) = 3.99,
p = 0.028, h2 = 0.20. Follow-up testing to clarify the nature of
this interaction revealed that the effect of Emotion was sig-
nificant in the placebo condition, F(2,32) = 4.81, p = 0.015,
h2 = 0.23, but not in the cortisol condition, F(2,32) = 0.68,
p = 0.52. In the placebo condition, the P2 amplitudes were
significantly larger (morepositive) for angry faces compared to
both neutral, F(1,16) = 7.93, p = 0.012, h2 = 0.33, and happy
faces F(1,16) = 4.60, p = 0.048, h2 = 0.22, but did not differ
significantly between happy and neutral faces, F(1,16) = 0.59,
p = 0.46. Cortisol administration tended to decrease the P2
amplitudes compared to placebo for angry faces,
F(1,16) = 3.88, p = 0.066, h2 = 0.20, but did not significantly
affect the P2 amplitudes for neutral, F(1,16) = 1.91, p = 0.19,
or happy faces, F(1,16) = 0.15, p = 0.71. No other effects
reached significance, all Fs < 2.2, ps > 0.12. The Condi-
tion  Emotion interaction remained significant when the
participants that scored above chance level on the awareness
check (n = 5)were excluded from the analyses, F(2,22) = 3.51,
Figure 1 Stimulus synchronized grand average ERP waveforms at midline electrodes (Fz, Cz, Pz) in the masked emotional Stroop task
after placebo (left) and cortisol (right) administration. Results showed a significant Condition  Emotion interaction at P2 and N2
components, reflecting significantly more positive amplitudes for angry faces in the placebo condition. This effect disappeared after
cortisol administration.
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placebo condition remained significantly more positive com-
pared to happy, F(1,11) = 5.42, p = 0.040, h2 = 0.33, and neu-
tral faces, F(1,11) = 5.11,p = 0.045, h2 = 0.32. In addition, the
decrease in P2 amplitudes after cortisol administration com-
pared to placebo for angry faces was now significant,
F(1,11) = 7.31, p = 0.021, h2 = 0.40.
3.3.2. N2 amplitude
The results of the N2 amplitudes in the masked task version
showed a significant main effect of Emotion, F(2,32) = 3.81,
p = 0.048, e = 0.74, h2 = 0.19, which was further qualified by a
significant Condition  Emotion interaction, F(2,32) = 3.97,
p = 0.029, h2 = 0.20. In line with the results of the P2 ampli-
tudes, the effect of Emotion was significant in the placebo
condition, F(2,32) = 6.92, p = 0.003, h2 = 0.30, but not after
cortisol administration, F(2,32) = 0.34, p = 0.71. In the pla-
cebo condition, the N2 amplitudes for angry faces were
significantly decreased (i.e., more positive) compared to
both neutral, F(1,16) = 8.85, p = 0.009, h2 = 0.36, and happy
faces, F(1,16) = 10.16, p = 0.006, h2 = 0.39. The difference in
N2 amplitude for neutral compared to happy faces was notsignificant, F(1,16) = 0.03, p = 0.87. Cortisol administration
resulted in significantly more negative N2 amplitudes com-
pared to placebo for angry faces, F(1,16) = 14.38, p = 0.002,
h2 = 0.47, but did not affect the N2 amplitudes for neutral,
F(1,16) = 0.14, p = 0.71) or happy faces, F(1,16) = 0.17,
p = 0.69. No other effects including Emotion or Condition
reached significance, all Fs < 3.1, ps > 0.07. The Condi-
tion  Emotion interaction remained significant when the
participants that scored above chance level on the awareness
check (n = 5) were excluded from the analyses,
F(2,22) = 5.12, p = 0.015, h2 = 0.32. The N2 amplitudes for
angry faces in the placebo condition remained significantly
decreased (i.e., more positive) compared to neutral,
F(1,11) = 9.22, p = 0.011, h2 = 0.46, and happy faces,
F(1,11) = 10.08, p = 0.009, h2 = 0.48, and the effect of corti-
sol administration on the N2 amplitudes for angry faces also
remained significant, F(1,11) = 15.67, p = 0.002, h2 = 0.59.
3.3.3. P3 amplitude
In contrast to the P2 and N2 amplitudes, the P3 amplitudes
did not show significant effects for Emotion, F(2,32) = 0.01,
p = 0.99, or Condition  Emotion, F(2,32) = 2.34, p = 0.11.
Table 4 Means (and standard errors) of peak amplitudes (mV) at midline and occipito-temporal electrodes as a function of
condition, task and stimulus emotion.
Masked Unmasked
Angry Neutral Happy Angry Neutral Happy
Midline
P2 Placebo 10.1 (1.4) 8.0 (1.4) 8.4 (1.3) 14.1 (1.1) 11.3 (12.3) 12.3 (1.3)
Cortisol 8.2 (1.2) 9.0 (1.3) 8.8 (1.3) 13.2 (1.2) 12.5 (1.4) 12.5 (1.4)
N2 Placebo 0.9 (1.3) 3.5 (1.3) 3.4 (1.5) 2.7 (1.5) 0.8 (1.6) 0.1 (1.7)
Cortisol 3.6 (1.3) 3.2 (1.2) 3.8 (1.2) 1.2 (1.5) 0.1 (1.4) 0.8 (1.4)
P3 Placebo 11.8 (1.6) 10.5 (1.5) 10.7 (1.3) 14.2 (1.8) 12.5 (1.4) 14.3 (1.6)
Cortisol 8.9 (1.0) 10.3 (1.4) 10.2 (1.3) 12.0 (1.4) 11.6 (1.5) 12.0 (1.4)
Occipito-temporal
N170 Placebo 3.0 (1.0) 4.0 (1.0) 3.5 (0.9) 8.5 (1.6) 8.6 (1.1) 9.1 (1.4)
Cortisol 3.3 (1.0) 2.9 (1.1) 3.6 (1.0) 8.1 (1.3) 7.7 (1.2) 8.2 (1.2)
P1 Placebo 7.4 (1.7) 7.0 (1.7) 7.7 (1.8) 6.4 (1.5) 6.4 (1.7) 6.9 (1.6)
Cortisol 8.1 (1.9) 8.1 (1.6) 8.9 (1.7) 6.7 (1.5) 7.5 (1.8) 7.4 (1.7)
P2 Placebo 16.6 (2.1) 15.7 (1.8) 16.0 (1.9) 13.5 (1.7) 14.0 (1.7) 13.3 (1.7)
Cortisol 16.5 (1.8) 17.2 (1.9) 17.3 (1.7) 13.4 (1.6) 14.0 (1.7) 12.8 (1.6)
Note: Midline at Fz/Cz/Pz electrodes; occipito-temporal: N170 at T5/T6 electrodes; P1 and P2 at O1/O2 electrodes.
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reached significance, all Fs < 3.8, ps > 0.05.
3.4. Occipito-temporal electrodes (T5, T6, O1,
O2)
The repeated measures ANOVAs showed no significant results
for the N170 amplitudes (T5, T6), all Fs < 3.2, ps > 0.05, or
the occipital P2 amplitudes (O1, O2), all Fs < 2.3, ps > 0.12,
in the masked task version. For the occipital P1 amplitudes
results showed a significant Emotion  Electrode interaction,
F(2,32) = 6.89, p = 0.003, h2 = 0.30, reflecting a significant
effect of Emotion at O2, F(2,32) = 3.89, p = 0.031, h2 = 0.20,
but this effect disappeared after the participants that scored
above chance level at the awareness check were excluded
from the analyses, F(2,22) = 2.32, p = 0.12. No other effects
reached significance, all Fs < 3.7, ps > 0.07. See Table 4.
3.5. ERP results unmasked task: midline
electrodes (Fz, Cz, Pz)
See Table 4 for mean amplitudes at midline and occipito-
temporal electrodes in the unmasked task.
3.5.1. P2 amplitude
In contrast to the results of the masked task, the interaction
of Condition  Emotion on the midline P2 amplitudes was not
significant in the unmasked task, F(2,32) = 1.85, p = 0.17. We
did find a significant main effect of Emotion, F(2,32) = 5.32,
p = 0.010, h2 = 0.25. Follow-up F-tests showed that the P2
amplitudes were significantly increased for angry compared
to neutral faces, F(1,16) = 12.94, p = 0.002, h2 = 0.45, and
showed a tendency in the same direction for angry compared
to happy faces, F(1,16) = 3.95, p = 0.064, h2 = 0.20. The
difference between the P2 amplitudes for neutral and happy
faces was not significant, F(1,16) = 0.95, p = 0.34. No other
effects including Emotion or Condition reached significance,
all Fs < 1.2, ps > 0.34.3.5.2. N2 amplitude
Results of the N2 amplitudes showed a significant Electro-
de Emotion interaction, F(4,64) = 7.09, p = 0.001, e = 0.62,
h2 = 0.31. Follow-up F-tests showed a significant effect of
EmotiononlyatPz,F(2,32) = 6.05,p = 0.006,h2 = 0.27,reflect-
ing significantly lessnegativeamplitudes forangrycomparedto
happy faces, F(1,16) = 11.24, p = 0.004, h2 = 0.41, and a trend
in the same direction for angry compared to neutral faces,
F(1,16) = 3.63,p = 0.075,h2 = 0.27.Thisresult is inlinewiththe
findings for themaskedtask.Noothereffects includingEmotion
or Condition reached significance, all Fs < 3.2, ps > 0.05.
3.5.3. P3 amplitude
In line with the findings of themasked task, the results for the
unmasked task version showed no significant effects involving
Emotion or Condition on the P3 amplitudes, all Fs < 1.9,
ps > 0.18.
3.6. Occipito-temporal electrodes (T5, T6, O1,
O2)
In line with the masked task, results of the unmasked task
version showed no significant effects on the N170 amplitudes
(T5, T6), all Fs < 4.4, ps > 0.05, or the occipital P2 ampli-
tudes (O1, O2), Fs < 2.2, ps > 0.16. The occipital P1 ampli-
tudes did not show any significant results in the unmasked
task either, all Fs < 2.25, ps > 12.
3.7. Relationship between threat processing and
social anxiety
Since previous studies have shown significant relationships
between ERP amplitudes during threat processing and sever-
ity of (social) anxiety (see Bar-Haim et al., 2005; Kolassa and
Miltner, 2006), including effects of cortisol administration
(van Peer et al., 2009) we explored whether any of the
significant ERP effects involving angry faces in the present
study were influenced by individual differences in social
Figure 2 Correlation between social anxiety (SPAI total score)
and cortisol-induced change in P2 amplitude for angry faces in
the masked emotional Stroop task (i.e., P2 masked angry
placebo  cortisol). Positive values on the x-axis indicate larger
P2 amplitudes on midline electrodes (Fz, Cz, Pz) in the placebo
condition, compared to the cortisol condition. The scatterplot
shows that high levels of social anxiety are associatedwith a larger
cortisol-induced decrease in P2 amplitudes for masked angry
faces, indicating a decrease in threat processing (after cortisol
administration) under conditions of restricted awareness. Note:
The correlation was somewhat depressed by one participant (see
the lower left corner of the graph). Without this participant the
correlation was R = 0.56, p = 0.024, but this person was no statis-
tical outlier (Mahalanobis D2 = 8.64, p = 0.02).
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continuous factor in the repeated measures analyses
(ANCOVA: see Judd et al., 2001) for the ERP amplitudes that
showed a significant effect for angry faces. Significant inter-
actions with social anxiety were followed up by calculating
Pearson correlations between social anxiety and the differ-
ence score of the relevant within-subjects factor.
Results showed that the effect of Condition on the P2
amplitudes for angry faces in themasked task was significantly
influenced by individual differences in social anxiety, as
reflected by a significant interaction of Condition with the SPAI
total score, F(1,15) = 5.63, p = 0.031, h2 = 0.27. Pearson cor-
relations between total scores on the SPAI and the cortisol-
inducedchange inP2amplitude formaskedangryfaces (i.e.,P2
amplitude masked angry placebo  cortisol) showed that the
direction of this correlation was positive (R = 0.52, p = 0.031),
indicating that patients with higher levels of social anxiety
showed a significantly stronger decrease in P2 amplitudes after
cortisol administration compared to placebo (see Figure 2).
This effect was not significant for the SPAI social phobia scores,
although the correlation showed the same direction of effects
(R = 0.33,p = 0.20).NoneoftheotherERPamplitudeeffects for
angry faces in this study were significantly associated with
individual differences in social anxiety.
4. Discussion
Themajor aims of the present study were to gainmore insight
in the temporal dynamics of biased processing of implicitsocial threat in SAD, and to explore the effect of cortisol
administration on such processing. This was investigated by
measuring ERPs during color-naming of masked and
unmasked emotional faces in a modified emotional Stroop
task after placebo and cortisol administration in participants
with a clinical diagnosis of generalized SAD.
4.1. Early processing advantage for angry faces
in SAD
First, the ERP results showed an early processing bias for
social threat stimuli in the placebo condition, as reflected by
increased (more positive) P2 amplitudes for angry compared
to neutral and happy faces, even when they were presented
under conditions of restricted awareness. ERP amplitudes for
angry faces continued to be significantly more positive in the
time-window of the N2 component on all electrodes in the
masked task, as well as on Pz electrode in the unmasked task.
Increased amplitudes of early positive frontocentral ERP
components in reaction to threat-related (i.e., angry or
fearful) emotional faces have previously been reported in
studies in healthy participants, and are generally interpreted
as reflecting increased allocation of processing resources to
motivationally significant stimuli (Eimer and Holmes, 2002;
Eimer et al., 2003; Bar-Haim et al., 2005; Williams et al.,
2006).
To our knowledge, the present study is the first showing
increased early processing of implicit social threat reflected
by ERPs in participants with a clinical diagnosis of SAD. This
finding is in line with a range of behavioral studies showing
hypervigilance to social threat in SAD (see Bar-Haim et al.,
2007; Mobini and Grant, 2007 for recent reviews), and pro-
vides support for the notion that such vigilance occurs in
early stages of information processing (e.g., Mogg et al.,
1997; Amir et al., 1998; Mogg and Bradley, 2002). ERP studies
investigating angry face processing in relation to (social)
anxiety are scarce, but there are some recent findings in
non-clinical samples providing support for increased early
threat processing in (socially) anxious participants. In line
with our results, Bar-Haim et al. (2005) found enhanced P2
amplitudes to angry faces in high compared to low trait
anxious healthy participants, indicating that implicit early
threat processing can be modulated by anxiety (cf. Holmes
et al., 2008; Moser et al., 2008). In addition, Rossignol et al.
(2007) reported facilitated detection of subtle changes in
anger expression during face repetition in participants with
non-clinical social anxiety compared to low socially anxious
participants, as reflected by a reduced N2b wave around
300 ms post-stimulus. Only a few previous ERP studies inves-
tigated angry face processing in participants with clinically
diagnosed SAD (Kolassa and Miltner, 2006; Kolassa et al.,
2007, 2009). In contrast to the present study, these found
no evidence for increased early processing of task-irrelevant
angry faces, although enhanced right temporo-parietal N170
amplitudes were found during explicit emotion identification
of angry faces in one study (Kolassa and Miltner, 2006). The
lack of a processing bias for implicit social threat in these
studies may be partly due to the use of schematic face stimuli
(Kolassa et al., 2007, 2009) which show a different electro-
physiological response pattern than photographic faces
(Kolassa et al., 2007) and may be less sensitive for detecting
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of these studies (Kolassa and Miltner, 2006; Kolassa et al.,
2007, 2009) focused on occipito-temporal electrodes and did
not report on the early and late midline positive ERP com-
ponents that we investigated in the present study, and which
have consistently demonstrated emotional expression
effects in healthy participants (see Holmes et al., 2008).
Emotional modulation of the N170 component has been less
consistently found and may be only present when the iden-
tification of the facial emotion is explicitly task-relevant, as
suggested by Kolassa et al. (2009, see also Kolassa and
Miltner, 2006), which would explain why we did not observe
this effect in the present study.
4.2. Effects of cortisol on implicit threat
processing
Our second main finding was that the early threat bias,
reflected by increased P2 amplitudes for angry faces, sig-
nificantly decreased (and disappeared) after cortisol admin-
istration in the masked task. Moreover, this effect was
stronger for participants with higher levels of social anxiety.
Both the finding that cortisol administration only significantly
affected P2 amplitudes for angry faces, and the finding that
the magnitude of this effect was related to severity of social
anxiety are consistent with the results of van Peer et al.
(2009). However, the direction of the effect of cortisol
administration in the present study was opposite to the
findings of this previous study. van Peer et al. (2009) inves-
tigated the effect of cortisol administration on ERPs in
patients with SAD using a RT paradigm measuring social
approach and avoidance behavior in reaction to happy and
angry faces. In contrast to the decrease in P2 amplitudes for
masked angry faces in the present study, the results of van
Peer et al. (2009) showed cortisol-induced increases in these
same amplitudes, indicating enhanced processing, during
avoidant responses to angry faces in patients with high levels
of social anxiety (see also van Peer et al., 2007). Notably,
both of these tasks (i.e., the approach-avoidance task of van
Peer et al. (2009) and the emotional Stroop task described in
the present article) were administered during the same
experiment, and thus concerned the same group of partici-
pants. Therefore, the contrasting findings are most likely
explained by task-related differences. First, cortisol only
significantly decreased P2 amplitudes formasked angry faces
in the present study, whereas stimuli in the previous study
were all unmasked. Several authors have suggested that
processing of unmasked threat stimuli may be affected by
mood-controlling strategies in high socially anxious indivi-
duals (e.g., Williams et al., 1996; Mogg and Bradley, 2002),
whereas such strategies are minimized during masked pre-
sentation. Consistent with this notion, behavioral evidence
for modulation of angry face processing by social anxiety has
been previously found in masked, but not unmasked facial
emotional Stroop tasks (Putman et al., 2004). Similarly, angry
face processing was significantly related to baseline endo-
genous cortisol levels in masked, but not unmasked versions
of this task (van Honk et al., 1998). Thus, masking has an
important influence on the processing of these stimuli, and
the preclusion of cognitive control processes could provide
grounds for an interaction with cortisol.A second important factor is that van Peer et al. (2009)
used an explicit affect-evaluation task, whereas the emo-
tional expression of the faces in the present task was implicit
and task-irrelevant. Several studies suggest that task-rele-
vance vs. irrelevance of emotional expression can have a
significant effect on ERPs related to early threat processing
(see e.g., Bar-Haim et al., 2005; Kolassa and Miltner, 2006;
Eimer and Holmes, 2007; Kolassa et al., 2009). Furthermore,
effects of cortisol on processing of negative or threatening
emotional information may differ depending on task-rele-
vance of these emotional stimuli. To our knowledge, only two
previous studies investigated effects of cortisol administra-
tion on processing of task-irrelevant (or distracting) emo-
tional stimuli. Putman et al. (2007b) reported increased
color-naming latencies (reflecting interference or threat
vigilance) for masked fearful compared to neutral faces on
an emotional Stroop task after placebo administration. This
effect was abolished after cortisol administration. Interest-
ingly, this cortisol-induced decrease in fear processing was
most pronounced in participants with high self-reported trait
anxiety. More recently, Oei et al. (2009) found reduced
interference by task-irrelevant negative pictures in a mod-
ified Sternberg working memory task after cortisol adminis-
tration compared to placebo. Although both of these studies
were conducted in healthy young men and did not use angry
face stimuli, the pattern of results (reduced processing of
task-irrelevant negative stimuli) is consistent with the pre-
sent findings. In contrast, the findings of van Peer et al.
(2009) are in line with other studies showing increased angry
face processing after cortisol administration in explicit emo-
tion evaluation paradigms (Putman et al., 2007a; van Peer
et al., 2007). Thus, task or goal-relevance may be an impor-
tant factor modulating the effects of corticosteroids on
information processing, resulting in cortisol-induced
increases in threat processing and avoidance when the sti-
muli are task-relevant, and inhibition of threat processing
when the emotional stimuli are task irrelevant or distracting.
These findings are consistent with the view that cortisol
generally facilitates processing and adaptive behavior that
is most relevant to the situation, as advocated by De Kloet
et al. (1999) based on animal studies. Further research is
needed to directly and systematically investigate the role of
such task-related factors on the effect of cortisol on early
attention processes.
The results of the present study suggest that social threat
stimuli automatically attract more attention in patients with
SAD at very early stages of information processing, and that
cortisol administration decreases this threat bias under con-
ditions of restricted awareness. There are, however, some
limitations that should be discussed.
First, we did not find any significant behavioral results,
although this is in line with the results of other studies in
patients with SAD using a similar paradigm (Kolassa and
Miltner, 2006). van Hooff et al. (2008) suggested that a lack
of behavioral findings in emotional Stroop studies with ERP
could be due to the use of relatively long inter-trial intervals
(ITIs, 2—4 s in the present study). However, previous beha-
vioral studies using the same paradigm (with long ITIs) as the
present study have shown it to be sensitive to detect atten-
tional biases in high socially anxious healthy participants (see
Putman et al., 2004), which makes this explanation less
likely. A second possibility, as described in the introduction,
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sensitive to detect attentional biases in social phobic
patients, because RT data reflect the combined product of
a range of cognitive processes, including possibly opposite
biases in early and late stages of information processing. For
this reason we included measurement of ERPs during task
performance. Nevertheless, the demonstration of an atten-
tional bias for threat using RTs would be helpful as a con-
firmatory measure to strengthen conclusions regarding ERP
effects (e.g., Holmes et al., 2009). Inclusion of a larger
subject sample is also recommended to increase the statis-
tical power to detect small or medium sized effects.
A second limitation is that we did not include a non-
anxious control group, and therefore cannot conclude
whether our finding of an early threat bias, or the effects
of cortisol on this bias, are specific to social anxiety. The
finding that effects of cortisol on early threat processing
were stronger in patients with higher levels of social anxiety
does provide tentative support for an increased sensitivity in
high anxious patients, although this is limited by the fact that
the participants are all within a restricted diagnostic range.
In addition, a recent study by Putman et al. (2007b) using a
highly similar Emotional Stroop task, showed a cortisol-
induced decrease in fear processing that was most pro-
nounced in healthy participants with high self-reported
levels of trait anxiety. This finding supports the notion that
anxious participants may show increased sensitivity to corti-
sol effects on threat processing compared to non-anxious
participants (see also Roelofs et al., 2009; van Peer et al.,
2007). Nevertheless, future ERP research including a
matched healthy control group is necessary to conclude
whether the effects of cortisol on implicit threat processing
as found in the present study are specific to (or increased in)
socially anxious participants, or reflect a process that can be
found in the general population.
Third, the masked task was administered prior to the
unmasked task in all participants in order to minimize the
chance that participants would consciously perceive the
masked facial expressions due to, for example, priming
effects. Although this does not affect our main findings, it
may have confounded effects of masking with effects of
repeated administration and should be accounted for in
future studies.
Finally, in the present study we administered cortisol to
investigate its causal influence on cognitive-emotional pro-
cesses that play an important role in social anxiety disorder.
Although exogenous administration studies are better suited
to investigate the causal role of cortisol compared to e.g.,
stress induction, as they constrain effects related to arousal
and noradrenergic activation, it should be noted that the
results of these studies cannot simply be generalized to nat-
uralistic situations with elevated cortisol levels. Thus, further
research is needed to assess the ecological validity of our
findings by comparing them with the effects of endogenous
cortisol increases. In addition, the effects of cortisol in the
present study relied on a single high (50 mg) dose, whereas
dose—response studies in the field of memory research have
shownan invertedU-shape relationshipbetweencognitionand
glucocorticoid (GC) levels. That is, very high and low GC doses
caused memory impairment, whereas moderate doses caused
memory enhancement (see e.g., Lupien et al., 1999). Future
studies including more moderate doses of cortisol are neededto investigate whether different doses of cortisol result in a
similar inverted U-shape effect on early threat processing.
To conclude, this study provided the first psychophysiolo-
gical evidence for increased early processing of implicit social
threat in participants with a clinical diagnosis of SAD, and
showed that cortisol administration decreased this threat bias
under conditions of restricted awareness. Together with pre-
vious findings (van Peer et al., 2009) these results indicate a
highly specific effect of cortisol on early motivated attention
to social threat, and highlight the importance of motivational
context (goal-relevance) and symptom severity.
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